Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Coronavirus disease 2019 in pregnancy
Xu Qiancheng1, Shen Jian2, Pan Lingling3
1Department of Critical Care Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), No. 2, West Road of Zheshan, Jinghu District, Wuhu, Anhui, 241000 China.
Pregnant women infected with COVID-19 show similar clinical outcomes and recovery times compared to non-pregnant women. Studies found no evidence of SARS-CoV-2 vertical transmission during late pregnancy or delivery.
Area of Science:
- Infectious Diseases
- Maternal-Fetal Medicine
- Virology
Background:
- COVID-19 (Coronavirus Disease 2019) poses risks to pregnant individuals.
- Understanding clinical differences and transmission in pregnancy is crucial for patient management.
Purpose of the Study:
- Compare clinical courses and outcomes of COVID-19 in pregnant versus non-pregnant women.
- Assess the potential for vertical transmission of SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2) in pregnancy.
Main Methods:
- Retrospective review of medical records for hospitalized pregnant and non-pregnant women with confirmed COVID-19.
- Analysis of disease severity, virus clearance time, and hospital stay duration.
- Evaluation of SARS-CoV-2 transmission to neonates.
Main Results:
- No significant association found between pregnancy and COVID-19 disease severity, virus clearance, or hospital stay length.
- Twenty-three live births occurred among 28 pregnant women; no neonates tested positive for SARS-CoV-2.
- Cesarean sections (60.7%) and vaginal deliveries (17.9%) were analyzed.
Conclusions:
- Pregnant women experience comparable clinical courses and outcomes to non-pregnant women with COVID-19.
- No evidence of vertical SARS-CoV-2 transmission was observed in late pregnancy or during delivery.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Teratogenicity
Mitral Valve Prolapse III: Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....